Sanquin: een onmisbare schakel voor het UMCG

Mo 24 February 2025

If you walk onto the UMCG site from the Oostersingel, you will see Sanquin at entrance 47. Sanquin is the national organization responsible for the blood supply in the Netherlands. They ensure that there is enough blood and blood products available for hospitals and other healthcare institutions. Since 2005, Sanquin has been located on the Healthy Ageing Campus in Groningen. Campus Groningen once visited this player on campus, which is the only organization in the Netherlands tasked by the ministry with ensuring the blood supply.

More demand for plasma donors

With over 400,000 active blood donors in the Netherlands, 2 out of 100 residents currently donate blood voluntarily. This helps about 100,000 patients annually. “That is of course fantastic,” says Karin Zuidema, location manager at Sanquin. “And currently the biggest challenge for Sanquin is recruiting enough plasma donors.” The demand for blood plasma increases by about 3% annually, while the demand for blood cells decreases. "We therefore ask some of our blood donors if they want to donate plasma. This takes a little more time, but it is essential for helping patients." Plasma consists of fluid and proteins and can be administered to patients with burns. The proteins can also serve as raw material for medicines.

Sanquin
"And currently the biggest challenge for Sanquin is recruiting enough plasma donors.” The demand for blood plasma increases by about 3% annually, while the demand for blood cells decreases. "We therefore ask some of our blood donors if they want to donate plasma. This takes a little more time, but it is essential for helping patients."

Karin Zuidema location manager at Sanquin

A careful process

How does that work? The process of blood and plasma donation at Sanquin is careful and efficient. Donors undergo an examination to determine whether it is safe (both for themselves and the recipient) to donate. In plasma donation, the plasma is separated from the blood cells. The donor then receives the blood cells back through the same needle. This causes less fatigue and the donated proteins and fluid are quickly replenished by the body. Therefore, donating plasma can be done more frequently than donating blood. All collected blood is sent to Nijmegen for processing. The blood products obtained there are then returned to Groningen for distribution to hospitals in Groningen and Drenthe.

Sanquin

The road to self-sufficient production

Thanks to Sanquin and Dutch donors, the Netherlands is self-sufficient in terms of blood transfusion products. But this does not apply to plasma as a basis for plasma medicines. In this area, the Netherlands still partly depends on imports of plasma medicines from international manufacturers. Looking to the future, Sanquin aims to make the Netherlands more self-sufficient in meeting the demand for plasma medicines.

On the Healthy Ageing Campus, Sanquin contributes to the mission of promoting healthy aging through regular health checks of donors, innovative products such as the development of eye drops from donor blood and scientific research in the field of anemia, blood clotting, immunotherapy and immunity & inflammation. Sanquin is also a founder of the Health Innovation District in Amsterdam, where companies within the biomedical sector are brought together to further innovate healthcare together.

The proximity of UMCG offers Sanquin significant advantages, including direct access to advanced medical facilities and close collaboration with leading researchers and specialists. This allows them to collaborate more quickly and efficiently on new medical insights and technologies, benefiting the quality of services and research on both sides.

Source article: Campus Groningen
Pictures: own images Sanquin

Maybe also interesting for you

Th 3 September 2026

From robotic surgery to early cancer detection: five innovations in the running for LIFE Science Innovation Award

Who is developing the most impactful innovation in Life Sciences & Health in the Northern Netherlands? Five companies are in the running for the LIFE Science Innovation Award 2026: Flux Robotics, Limosa Immunodiagnostics, SPCTR, MimeCure and GlycanScan International. The nominees will present their innovations on Tuesday 22 September during the fifth edition of the LIFE Science Conference in Groningen. An independent jury will select the winner, who will receive a €10,000 cash prize.

We 2 September 2026

Record number of participants for Campus Trail

A much-loved tradition The Campus Trail has become a much-loved tradition on campus. Students, employees and professionals from companies and organisations across the campus ecosystem lace up their running shoes for a sporty 6.4-kilometre route through buildings and past some of the campus’s unique labs. The rapid growth in registrations shows just how much the Campus Trail has become part of the campus community. The combination of sport, meeting others and the unique campus setting makes the run a great opportunity to connect with people outside the usual work and study environment. And there’s no need to head home as soon as you cross the finish line. During the after-party, hosted by Contini Catering, participants can relax together, enjoy a drink and celebrate the afternoon. There’s still time to join: those who want to take part can register online until 3 September, or sign up on the day itself using the PIN Campus Trail 2026 | Campus Groningen.

Tu 18 August 2026

Advance Notice: New Round of Shared Development Infrastructure Grants

ZonMw is expected to open the final call for proposals within the PharmaNL Shared Development Infrastructure (SDI) program line. This program line focuses on strengthening the infrastructure for the development, upscaling, and production of innovative medicines in the Netherlands.